ArticlemedRxiv : the preprint server for health sciences2025
Individual-specific resting-state networks predict language dominance in drug-resistant epilepsy.
Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
8 authors.
Funding
Abstract
Importance: Identifying language dominance is a crucial step in epilepsy surgery planning. We applied a precision functional brain mapping approach to estimate individual-specific cortical resting-state networks in drug-resistant epilepsy and predict language dominance. Objective: To determine whether individual-specific cortical network topography can predict task-based language dominance in drug-resistant epilepsy. Design: Retrospective case-control study conducted between January 2024 and August 2025. Setting: Multicentre population-based study including healthy participants from the Human Connectome Project, and participants with drug-resistant epilepsy from the National Institutes of Health (NIH) and the University of Iowa. Participants: Eligible participants had drug-resistant epilepsy defined by International League Against Epilepsy criteria and were undergoing pre-surgical evaluation. All participants underwent neuroimaging, with a subset receiving concurrent intracranial electrical stimulation during fMRI. Main Outcomes and Measures: Individual-specific cortical network topography and prediction of task functional magnetic resonance imaging language dominance. Results: Ninety-one participants with drug-resistant epilepsy were included: 61 (67.0%) temporal lobe epilepsy, 29 (31.9%) extra-temporal lobe epilepsy, and 1 (1.1%) undetermined seizure onset zone. The mean age was 33.0 ± 11.4 years and 50 (54.9%) were male. There were 40 healthy participants with a mean age of 29.0 ± 4.0 years, and 16 (40.0%) were male.We developed a multi-session hierarchical Bayesian model (MS-HBM) trained on NIH data to estimate individual-specific networks in drug-resistant epilepsy. MS-HBM trained on epilepsy data outperformed group-average networks or MS-HBM trained on healthy participants and generalized well to an independent dataset. During concurrent intracranial electrical stimulation, cortical activation and deactivation aligned more closely to individual-specific networks than group-average networks. Individual-specific language network topography significantly differed across left (mean lateralization index (LI) = 0.165 ± 0.106; area-under-the-curve (AUC) = 0.82), bilateral (LI = 0.056 ± 0.074; AUC = 0.72), and right (LI = 0.023 ± 0.055; AUC = 0.83) language dominance groups (p = 0.002). Conclusions and Relevance: Our model is publicly available (github link), which may be used to predict language dominance from approximately 10 minutes of resting-state fMRI. This provides a practical, non-invasive tool for presurgical evaluation of drug-resistant epilepsy.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.